| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | SANAI HEALTH GP (01889): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | - | HKEx | ||
| Mi | SANAI HEALTH GP (01889): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| Mi | SANAI HEALTH GP (01889): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | - | HKEx | ||
| Mi | SANAI HEALTH GP (01889): PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 26 JUNE 2026 (OR ANY ADJOURNMENT THEREOF) | - | HKEx | ||
| Mi | SANAI HEALTH GP (01889): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| Mi | SANAI HEALTH GP (01889): (1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; (2) PROPOSED EXTENSION OF ISSUE MANDATE; (3) PROPOSED ... | - | HKEx | ||
| Mi | SANAI HEALTH GP (01889): ANNUAL REPORT 2025 | 1 | HKEx | ||
| SANAI HEALTH INDUSTRY GROUP Aktie jetzt für 0€ handeln | |||||
| 31.03. | SANAI HEALTH GP (01889): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 | - | HKEx | ||
| 27.03. | SANAI HEALTH GP (01889): PROFIT WARNING | 2 | HKEx | ||
| 19.03. | SANAI HEALTH GP (01889): DATE OF BOARD MEETING | 1 | HKEx | ||
| 19.12.25 | SANAI HEALTH GP (01889): CLARIFICATION AND SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 | 1 | HKEx | ||
| 10.11.25 | SANAI HEALTH GP (01889): DISCLOSEABLE TRANSACTION - DISPOSAL OF SUBSIDIARY | 2 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GSK | 22,340 | +1,13 % | JPMORGAN stuft GSK auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat GSK nach Quartalszahlen mit einem Kursziel von 1700 Pence auf "Underweight" belassen. Dass der Pharmakonzern die Erwartungen übertroffen habe,... ► Artikel lesen | |
| BIOTEST | 32,600 | +1,24 % | Biotest erhält FDA-Zulassung | Summary: FDA lässt Fibrinogen-Produkt für den US-Markt zu Biotest entwickelt und produziert, Grifols vermarktet Markteinführung für 2026 geplant Pipeline gewinnt strategisch an Gewicht Biotest hat einen... ► Artikel lesen | |
| KHIRON LIFE SCIENCES | 0,029 | -100,00 % | Khiron Life Sciences Corp: Khiron Life Sciences warrants to expire Nov. 26 | ||
| CHRISTINA LAKE CANNABIS | 0,012 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake investor Milia acquires 5.03M shares | ||
| PSYCHED WELLNESS | 0,009 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector | Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,002 | 0,00 % | Greenrise Global Brands Inc: Greenrise Global Brands to file 2025 financials late | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 23.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.04.2026ISIN NameAU000000BMG3 BMG... ► Artikel lesen | |
| BETTERLIFE PHARMA | 0,034 | 0,00 % | BetterLife Pharma Inc.: BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco | Vancouver, British Columbia--(Newsfile Corp. - January 6, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biopharmaceutical company... ► Artikel lesen | |
| SHIONOGI | 17,600 | +0,95 % | Shionogi USA: ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of Fetroja/Fetcroja (cefiderocol) in MBL-Producing Enterobacterales Infections | Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase... ► Artikel lesen | |
| MEDIPHARM LABS | 0,053 | +0,95 % | Medipharm Labs Corp: Medipharm welcomes U.S. cannabis product restructuring | ||
| ADDEX THERAPEUTICS | 0,041 | -10,87 % | Addex Therapeutics: Addex Reports Full Year 2025 Financial Results and Provides Corporate Update | GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive activity in multiple disease modelsContinued to reposition dipraglurant mGlu5 NAM for brain injury... ► Artikel lesen | |
| PROMINO NUTRITIONAL SCIENCES | 0,024 | 0,00 % | Promino Nutritional Sciences, Inc.: Promino Provides Update Respecting Private Placement | Burlington, Ontario--(Newsfile Corp. - April 22, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company") announces, further to its news release... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,015 | -9,09 % | ARGENT BIOPHARMA LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | ||
| CANNABIST COMPANY | 0,020 | 0,00 % | XFRA VW5: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCANNABIST CO.HLDG.INC... ► Artikel lesen | |
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Announces Appointment of Jason Ware as CFO | NEW YORK and TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates and partners with regulated cannabis... ► Artikel lesen |